Pegylated Liposomal Doxorubicin (PLD) Versus Active Surveillance for Advanced Soft Tissue Sarcoma Patients Who Had Controlled Disease After Standard Anthracycline-based Treatment (MELODY)
Pegylated Liposomal Doxorubicin (PLD) Versus Active Surveillance for Advanced Soft Tissue Sarcoma Patients Who Had Controlled Disease After Standard Anthracycline-based Treatment (MELODY)
Recruiting · NCT06981637 · Registry updated 2026-07-02Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Pegylated Liposomal Doxorubicin (PLD) Versus Active Surveillance for Advanced Soft Tissue Sarcoma Patients Who Had Controlled Disease After Standard Anthracycline-based Treatment (MELODY) | Advanced Soft Tissue Sarcoma | Recruiting | Phase 2 | 2026-07-02 | NCT06981637 |
8 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Chang Gung Memorial Hospital | Kaohsiung City | Taiwan | 4 |
| China Medical University Hospital | Taichung | Taiwan | 54 |
| Kaohsiung Medical University Chung-Ho Memorial Hospital, | Kaohsiung City | Taiwan | 2 |
| National Cheng Kung University Hospital | Tainan | Taiwan | 53 |
| National Taiwan University Hospital | Taipei | Taiwan | 203 |
| Taipei Veterans General Hospital | Taipei | Taiwan | 64 |
| Tri-Service General Hospital | Taipei | Taiwan | 27 |